Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Michael Mano

General Counsel at Karyopharm Therapeutics Inc. (KPTI)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $36K

Reported trades

Filed Stock Type Shares Price Value Since
May 15SEC KPTIKaryopharm Therapeutics Inc. Sell 26694,398 held (−0%) $9.50 $3K -95.9%
Mar 3SEC KPTIKaryopharm Therapeutics Inc. Sell 3,52693,964 held (−4%) $9.41 $33K -95.9%